Filing metadata

Accession number
0001415889-23-012522
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Aug 22, 2023
Reporting period
Aug 20, 2023
Description
Insider transaction

Explore SEC Filings Hub